Nanjing Medlander (China) Top Management
688273 Stock | 25.20 0.33 1.33% |
Nanjing Medlander employs about 481 people. The company is managed by 8 executives with a total tenure of roughly 1123 years, averaging almost 140.0 years of service per executive, having 60.13 employees per reported executive. Analysis of Nanjing Medlander's management performance can provide insight into the company performance.
Ruijia Yang Chairman Chairman Manager |
Nanjing |
Nanjing Medlander Management Team Effectiveness
The company has return on total asset (ROA) of 0.0386 % which means that it generated a profit of $0.0386 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0776 %, meaning that it generated $0.0776 on every $100 dollars invested by stockholders. Nanjing Medlander's management efficiency ratios could be used to measure how well Nanjing Medlander manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Non Currrent Assets Other is expected to grow to about 28.8 M, whereas Total Assets are forecasted to decline to about 1.1 B.Nanjing Medlander Quarterly Income Before Tax |
|
Nanjing Medlander Workforce Comparison
Nanjing Medlander Medical is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 2.8 Million. Nanjing Medlander adds roughly 481 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.31 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.31. Nanjing Medlander Medical Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Nanjing Medlander Medical Price Series Summation is a cross summation of Nanjing Medlander price series and its benchmark/peer.
Nanjing Medlander Notable Stakeholders
A Nanjing Medlander stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Nanjing Medlander often face trade-offs trying to please all of them. Nanjing Medlander's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Nanjing Medlander's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ruijia Yang | Chairman Manager | Profile | |
Bin Chen | Director Manager | Profile | |
Ning Xu | Financial Director | Profile | |
Zhihuai Shi | Deputy Director | Profile | |
Wang Wang | Deputy Manager | Profile | |
Bisheng Zhu | Deputy Manager | Profile | |
Honglin Tu | Deputy Manager | Profile | |
Jiangning Chen | Deputy Secretary | Profile |
About Nanjing Medlander Management Performance
The success or failure of an entity such as Nanjing Medlander Medical often depends on how effective the management is. Nanjing Medlander management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Nanjing management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Nanjing management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Nanjing Medlander is entity of China. It is traded as Stock on SHG exchange.
Please note, the presentation of Nanjing Medlander's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nanjing Medlander's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Nanjing Medlander's management manipulating its earnings.
Nanjing Medlander Workforce Analysis
Traditionally, organizations such as Nanjing Medlander use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Nanjing Medlander within its industry.Nanjing Medlander Manpower Efficiency
Return on Nanjing Medlander Manpower
Revenue Per Employee | 708.6K | |
Revenue Per Executive | 42.6M | |
Net Income Per Employee | 186.7K | |
Net Income Per Executive | 11.2M | |
Working Capital Per Employee | 2.2M | |
Working Capital Per Executive | 129.8M |
Complementary Tools for Nanjing Stock analysis
When running Nanjing Medlander's price analysis, check to measure Nanjing Medlander's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanjing Medlander is operating at the current time. Most of Nanjing Medlander's value examination focuses on studying past and present price action to predict the probability of Nanjing Medlander's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanjing Medlander's price. Additionally, you may evaluate how the addition of Nanjing Medlander to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |